PVP-I Use Cases

Articles

July 18, 2025

Can a 0.23% Povidone-Iodine Rinse Shorten COVID-19? A Pilot Study Offers Encouraging Clues

We’ve talked a lot about povidone-iodine (PVP-I) as a potential virus killer, but how does it hold up in the real world—especially in people who already have COVID-19? A recent clinical pilot study from King Saud University Medical City set out to find answers by testing whether low-dose PVP-I nasal rinses and mouthwashes could reduce viral load and shorten the infectious period.

Read Now

PVP-I Use Cases

July 18, 2025

Protecting Healthcare Workers and Patients: The Role of Povidone-Iodine Mouthwash and Nasal Spray in COVID-19 Prevention

During the peak of the COVID-19 pandemic, healthcare workers faced immense exposure risks—often with limited options for protection beyond PPE. But what if a simple mouthwash or nasal spray could offer an additional line of defense? A comprehensive paper explores how povidone-iodine (PVP-I) products might reduce transmission between patients and health professionals alike. Here's how this low-cost, science-backed solution could play a vital role in infection control.

Read Now

PVP-I Use Cases

July 18, 2025

Can Povidone-Iodine Kill COVID-19 in Just 15 Seconds? New Lab Study Says Yes

While masks and vaccines have dominated COVID-19 headlines, another line of defense has been quietly gaining ground: antiseptic nasal sprays. One in particular—povidone-iodine (PVP-I)—has shown remarkable results in lab studies. A new in vitro (test tube) study published in JAMA Otolaryngology reveals just how fast and effective this simple nasal antiseptic can be against SARS-CoV-2, the virus behind COVID-19.

Read Now

PVP-I Use Cases

July 18, 2025

Phase II Trial Confirms 0.5% Povidone-Iodine Nasal Spray Can Reduce COVID-19 Viral Shedding

What if a simple nasal spray could help stop the spread of COVID-19? A new Phase II clinical trial investigating the effects of a 0.5% povidone-iodine nasal spray (Nasodine®) suggests just that. The trial builds on prior lab and pilot studies, confirming the spray’s effectiveness at reducing SARS-CoV-2 viral shedding in infected individuals. Here’s what the latest evidence tells us.

Read Now

PVP-I Use Cases

July 18, 2025

Can 0.5% Povidone-Iodine Nasal Spray Stop COVID-19 Spread? New Study Says Yes

As COVID-19 continues to evolve, scientists are constantly searching for simple, safe tools to reduce transmission. One such tool? The humble nasal spray. A new study explores how a 0.5% povidone-iodine (PVP-I) nasal spray—commonly known for its antiseptic properties—could help reduce viral shedding and potentially limit the spread of SARS-CoV-2. Here’s what the research found and what it means for public health

Read Now

PVP-I Use Cases

July 16, 2025

Can Povidone-Iodine Reduce COVID-19 Risk in Head and Neck Surgery?

Could a simple rinse reduce the danger of viral spread during surgery? This study explores how povidone-iodine might protect surgical teams during high-risk head and neck procedures.

Read Now

PVP-I Use Cases

July 16, 2025

Can Povidone-Iodine Replace Mupirocin for Nasal Decolonization? The Science Says Maybe

Staphylococcus aureus, particularly MRSA, remains a major threat in hospitals worldwide. Efforts to reduce infection risks focus heavily on decolonizing the nose—a common site where the bacteria live undetected. Traditionally, mupirocin and chlorhexidine have been the gold standards. But resistance is growing.

Read Now